Biotech Values

[DewDiligence]

ATNM’s 13D/A filing by Memorial Sloan Kettering does include a standstill agreement—see page 12 of Exhibit 1:

http://www.sec.gov/Archives/edgar/data/1388320/000092189515002854/ex1to13da210109002_12232015.htm

So long as the Company is in compliance with its obligations under this Agreement, then unless approved in advance by the Board of Directors of the Company, each Holder agrees that neither it nor any of its Representatives acting on behalf of such Holder will, for a period ending immediately after the annual shareholders meeting of the Company in 2016 (and in all events no later than December 31, 2016), directly or indirectly:

…in the case of MSKCC together with any of its Affiliates, acquire (or propose or agree to acquire), of record or beneficially, by purchase or otherwise, any equity securities representing in aggregate more than one percent (1%) of outstanding voting power in shares of the Company, or rights or options to acquire interests in any of the Company’s equity securities representing in aggregate more than one percent (1%) of outstanding voting power in shares of the Company.

p.s. The number of ATNM shares owned by MSKCC (5.7M) is the same as it has been since 12/28/12 (http://www.sec.gov/Archives/edgar/data/1388320/000118811213000127/t75355_sc13d.htm ).